These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9150615)
21. CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Kaye WH; Ballenger JC; Lydiard RB; Stuart GW; Laraia MT; O'Neil P; Fossey MD; Stevens V; Lesser S; Hsu G Am J Psychiatry; 1990 Feb; 147(2):225-9. PubMed ID: 1689122 [TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid monoamine precursors and metabolites in human neonates following in utero cocaine exposure: a preliminary study. Needlman R; Zuckerman B; Anderson GM; Mirochnick M; Cohen DJ Pediatrics; 1993 Jul; 92(1):55-60. PubMed ID: 8516085 [TBL] [Abstract][Full Text] [Related]
23. Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus. Lambert G; Naredi S; Edén E; Rydenhag B; Friberg P Brain Res Bull; 2002 May; 58(1):77-82. PubMed ID: 12121816 [TBL] [Abstract][Full Text] [Related]
24. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid. Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997 [TBL] [Abstract][Full Text] [Related]
25. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder. Lepola U; Jolkkonen J; Rimón R; Riekkinen P Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580 [TBL] [Abstract][Full Text] [Related]
26. Effects of the alpha 2-antagonist idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits. Dillen L; Claeys M; De Potter WP Eur J Pharmacol; 1987 May; 137(1):33-40. PubMed ID: 2440704 [TBL] [Abstract][Full Text] [Related]
27. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Lappalainen J; Long JC; Virkkunen M; Ozaki N; Goldman D; Linnoila M Biol Psychiatry; 1999 Sep; 46(6):821-6. PubMed ID: 10494451 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. Coplan JD; Trost RC; Owens MJ; Cooper TB; Gorman JM; Nemeroff CB; Rosenblum LA Arch Gen Psychiatry; 1998 May; 55(5):473-7. PubMed ID: 9596051 [TBL] [Abstract][Full Text] [Related]
35. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats. Togashi H; Matsumoto M; Yoshioka M; Hirokami M; Minami M; Saito H Neurosci Lett; 1994 Jan; 166(1):117-20. PubMed ID: 7514774 [TBL] [Abstract][Full Text] [Related]
36. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease. Poceta JS; Parsons L; Engelland S; Kripke DF Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455 [TBL] [Abstract][Full Text] [Related]
37. Effects of clonidine on central and peripheral nerve tone in primary hypertension. Sullivan PA; De Quattro V; Foti A; Curzon G Hypertension; 1986 Jul; 8(7):611-7. PubMed ID: 3721561 [TBL] [Abstract][Full Text] [Related]
38. A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia. Messiha FS J Neurol Sci; 1974 Jan; 21(1):39-46. PubMed ID: 4216622 [No Abstract] [Full Text] [Related]
39. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome. Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853 [TBL] [Abstract][Full Text] [Related]
40. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa. Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]